Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

SSE:688621.SS

54.23 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 590.579565.564644.23514.421719.174690.931599.259536.365502.014608.93559.003664.984581.53490.251271.282584.09770.535109.30561.05398.928
Short Term Investments 80305020303030.10730.10730.10713.10733.18.154.1157.6-14.0512735.09034152.979
Cash and Short Term Investments 670.579595.564694.23534.421749.174720.931629.366566.472532.121622.037592.103673.084635.63647.851271.282611.09770.535109.30595.05398.928
Net Receivables 842.044785.117796.074773.936636.262555.831557.607498.732447.953362.734337.202267.116254.046258.249181.666145.949138.905112.778105.33892.718
Inventory 15.07715.04615.38214.40116.57514.40914.66913.30113.16112.53711.2311.33111.637.847.046.8046.886.2895.0823.392
Other Current Assets 129.637118.76579.95395.981176.80965.96767.57366.26854.94242.65537.43445.56458.47327.845334.82736.29283.57334.50329.741101.861
Total Current Assets 1,657.3371,514.4921,585.641,418.7391,503.5531,357.1381,269.2151,144.7731,048.1781,039.963977.969997.095959.78941.785794.814800.241299.892262.875235.214204.18
Non-Current Assets:
Property, Plant & Equipment, Net 200.666211.611215.157229.657213.06220.264189.498189.149193.047197.017191.524184.838170.512161.052122.112103.58872.54574.6473.40965.989
Goodwill 26.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.05726.057
Intangible Assets 4.7445.4114.5664.9255.2335.3875.5973.6973.9764.1994.4775.9876.0383.3243.4873.7313.9354.0413.7163.906
Goodwill and Intangible Assets 30.80131.46830.62330.98231.2931.44431.65429.75430.03430.25630.53432.04432.09529.38129.54429.78829.99230.09829.77329.964
Long Term Investments 35.80275.802120.857109.857109.857100.85770.64370.64370.64381.64326.931.9-14.1-117.654.05111.6712.05513.15812.47811.854
Tax Assets 72.19464.03958.17954.98146.31738.92930.62927.14621.43716.08115.8448.367.0615.0342.4182.2612.232.6552.5283.048
Other Non-Current Assets 138.43889.89267.68156.75281.435114.387135.937131.179135.23598.134118.95192.089131.475222.99813.4652.0854.8461.4292.2233.591
Total Non-Current Assets 477.901472.811492.498482.23481.959505.88458.361447.87450.396423.131383.754349.231327.044300.866221.589149.393121.667121.98120.412114.446
Total Assets 2,135.2381,987.3042,078.1371,900.9681,985.5121,863.0181,727.5761,592.6431,498.5731,463.0941,361.7231,346.3261,286.8241,242.6511,016.404949.634421.559384.855355.626318.626
Liabilities & Equity:
Current Liabilities:
Account Payables 34.78137.69690.00728.00737.44956.76642.11544.00245.39333.03119.32121.5620.05818.35512.5620.93510.35913.62813.18520.838
Short Term Debt 486.132309.391354.802344.227439.678407.536315.888300.357241.912201.172243.099245.895187.204156.98449.935302533.3231529.594
Tax Payables 16.41817.02240.47421.81639.81530.51326.15524.24426.42420.87416.82816.44617.09417.47115.77111.9567.8977.1223.9426.981
Deferred Revenue 000255.329335.886292.666280.656219.782152.509205.855138.58400238.142179.831153.104167.134152.571152.726.981
Other Current Liabilities 476.087414.455359.204316.181-11.74769.17344.89439.73843.435263.11622.196179.707211.01225.16416.61825.984164.109137.864152.858118.914
Total Current Liabilities 1,013.418778.564844.487710.231841.081761.205659.872584.652509.672518.192440.029463.609435.368417.826245.818219.362207.365191.937184.985183.309
Non-Current Liabilities:
Long Term Debt 88.463102.322100.306108.284133.99640.62325.52326.62529.94633.84536.08542.15941.91549.72322.7869.861031.01700
Deferred Revenue Non-Current 3.272.523.6853.6853.5853.5852.0851.8252.8252.8255.565.065.065.46000000
Deferred Tax Liabilities Non-Current 0.0831.2460.250.1620.8490.347-2.085-1.825-2.825-2.825-5.56-5.06-5.06-5.46000000
Other Non-Current Liabilities 0003.685000000.2430000000-31.01700
Total Non-Current Liabilities 91.816106.088104.241108.445138.4344.55427.60828.4532.77136.6741.64547.21946.97555.18322.7869.8610000
Total Liabilities 1,105.234884.652948.728818.676979.511805.76687.479613.102542.443554.862481.674510.827482.343473.009268.604229.223207.365191.937184.985183.309
Equity:
Preferred Stock 000037.95637.95600000000000000
Common Stock 112112112112112112112112808080808080808060606060
Retained Earnings 592.941563.362605.098564.461488.643415.889416.579363.497341.439293.502279.002237.48204.698171.298158.24132.07393.64273.10754.95121.23
Accumulated Other Comprehensive Income/Loss 00044.2770-0491.19623.35523.19623.35510.65110.805510.65110.805503.1793.3330-00116.64
Other Total Stockholders Equity 325.275425.275413.818413.818413.818512.1230491.1960522.9380510.6510510.6510503.17952.66452.66452.664133.894
Total Shareholders Equity 1,030.2161,100.6371,130.9161,090.2791,014.4611,040.0121,019.775966.693944.636896.698869.653828.131795.349761.949741.418715.251209.64189.105167.615133.894
Total Equity 1,030.0041,102.6521,129.4091,078.6071,006.0021,057.2591,040.096979.541956.131908.232880.049835.498804.48769.642747.8720.411214.194192.918170.641135.317
Total Liabilities & Shareholders Equity 2,135.2381,987.3042,078.1371,900.9681,985.5121,863.0181,727.5761,592.6431,498.5731,463.0941,361.7231,346.3261,286.8241,242.6511,016.404949.634421.559384.855355.626318.626